Prevention of early-onset neonatal group B streptococcal infection: Is universal screening by culture universally applicable?

Israel Medical Association Journal

Volumn 8, Issue 10, 2006, Pages 698-702

  Eisenberg, Vered H ^a,c,d   Raveh, David ^a,c   Meislish, Yair ^a,c   Rudensky, Bernard ^a,c   Ezra, Yossef ^a,c   Samueloff, Arnon ^a,c   Eidelman, Arthur I ^a,b,c   Schimmel, Michael S ^a,c  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d NONE   (Israel)

Author keywords

Group B streptococcus; Neonatal sepsis; Prevention strategies; Screening culture; Serotype V

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CONTROLLED STUDY; CULTURE MEDIUM; DATA COLLECTION METHOD; DEMOGRAPHY; DISEASE CARRIER; ETHNOLOGY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTRAPARTUM CARE; INTRAUTERINE INFECTION; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MASS SCREENING; NEWBORN; NEWBORN INFECTION; ONSET AGE; PERINATAL CARE; PRENATAL SCREENING; RISK ASSESSMENT; RISK FACTOR; SAMPLING; SEROTYPE; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VAGINA SMEAR;

ADULT; AGE OF ONSET; ANTIBIOTIC PROPHYLAXIS; DISEASE TRANSMISSION, VERTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; ISRAEL; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 33750720333     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Center for Disease Control and Prevention. Decreasing incidence of perinatal group B streptococcal disease - United States, 1993-1995. MMWR 1997;46:473-7.
2. Schrag S, Gorwitz R, Fultz-Butts K, Shuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51(RR-11):1-22.
3. Eidelman AI, Rudensky B, Turgeman D, Nubani N, Schimmel MS, Isachson M. Epidemiology of perinatal group B streptococci colonization and disease in mothers and infants. Update of ongoing 10 years Jerusalem study. Isr J Med Sci 1990;26:71-3.
4. Schimmel MS, Eidelman AI, Rudensky B, et al. Epidemiology of group B streptococcal colonization and infection in Jerusalem 1989-1991. Isr J Med Sci 1994;30:349-51.
5. Schimmel MS, Samueloff A, Eidelman AI. Prevention of neonatal group B streptococcal infections. Is there a rational prevention strategy? Clin Perinatol 1998;25:687-97.
6. Rosenstein NE, Schuchat A. Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. The Neonatal Group B Streptococcal Disease Study Group. Obstet Gynecol 1997;90:901-6.
7. Brozanski BS, Jones JG, Krohn MA, Sweet RL. Effect of a screening-based prevention policy on prevalence of early-onset group B streptococcal sepsis. Obstet Gynecol 2000;95:496-501.
8. Rouse DJ, Goldenberg RL, Cliver SP, Cutter GR, Mennemeyer ST, Fargason CA. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 1994;83:483-94.
9. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811-15.
10. Main EK, Slagle T. Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: the superiority of culture-based protocols. Am J Obstet Gynecol 2000; 182:1344-54.
11. Strickland DMN, Yeomana ER, Hankins GDV. Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization. Am J Obstet Gynecol 1990;163:4-8.
12. Boyer KM. Maternal screening in prevention of neonatal infections: current status and rationale for group B streptococcal screening. J Hosp Infect 1998;11(Suppl A):328-33.
13. Fargason CA, Peralta-Carcelen M, Rouse DJ, Cutter GR, Goldenberg RL. The pediatric costs of strategies for minimizing the risk of early-onset group B streptococcal disease. Obstet Gynecol 1997; 90:347-52.
14. Cronin M, Walker A, Leeson S, Dunkin K, Markland M. Neonatal group B streptococcal disease. Lancet 2001;357:1045.
15. Halliday E, Foote K, Dryden M, Heard M, Down R, Ward J. Universal maternal screening for neonatal group B streptococcal disease. Lancet 2000;356:1407-8.
16. Marchaim D, Hallak M, Gortzak-Uzan L, Peled N, Riesenberg K, Schlaeffer F. Risk factors for carriage of group B streptococcus in southern Israel. IMAJ 2003;5:646-8.
17. Tsolia M, Psoma M, Gavrili S, et al. Group B streptococcus colonization of Greek pregnant women and neonates: prevalence, risk factors and serotypes. Clin Microbiol Infect 2003;9:832-8.
18. Arisoy AS, Altinisk B, Tunger O, Kurutepe S, Ispahi C. Maternal carriage and antimicrobial resistance profile of group B Streptococcus. Infection 2003;31:244-6.
19. Al-Sweih N, Maiyegun S, Diejomaoh M, et al. Streptococcus agalactiae (Group B Streptococci) carriage in late pregnancy in Kuwait. Med Princ Pract 2004;13:10-14.
20. Orrett FA. Colonization with group B Streptococci in pregnancy and outcome of infected neonates in Trinidad. Pediatr Int 2003;45: 319-23.
21. Trijbels-Smeulders MAJM, Kollee LAA, Adriaanse AH, Kimpen JLL, Gerards LJ. Neonatal group B streptococcal infection: Incidence and strategies for prevention in Europe. Pediatr Infect Dis J 2004;23:172-3.
22. Lin FY, Clemens JD, Azimi PH, et al. Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection. J Infect Dis 1998;177:790-2.
23. Hickman ME, Rench MA, Ferrieri P, Baker CJ. Changing epidemiology of group B streptococcal colonization. Pediatrics 1999;104: 203-9.
24. Glasgow TS, Young PC, Wallin J, et al. Association of intrapartum antibiotic exposure and late-onset serious bacterial infections in infants. Pediatrics 2005;116:696-702.
25. Shrim A, Beiner M, Weisz B, Seidman DS. Perinatal group B streptococcal disease: a review and revised guidelines for prevention. Harefuah 2004;143:520-4 (Hebrew).